Bank of New York Mellon’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bank of New York Mellon’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,615	Closed	-$43K	–	4744
2022 Q1	$43K	Hold	10,615	–	–	﹤0.01%	4544
2021 Q4	$85K	Sell	10,615 -58,049	-85%	-$680K	﹤0.01%	4427
2021 Q3	$1.32M	Buy	68,664 +58,326	+564%	+$1.02M	﹤0.01%	3238
2021 Q2	$143K	Hold	10,338	–	–	﹤0.01%	4159
2021 Q1	$93K	Buy	+10,338	New	+$75.6K	﹤0.01%	4175
2017 Q1	–	Sell	-1,762	Closed	-$23K	–	4343
2016 Q4	$23K	Buy	+1,762	New	+$64.7K	﹤0.01%	4207

Other funds holding PLXP

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon's PLXP Position: Q2 2022 in Review

Bank of New York Mellon sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2022, closing a stake of 10,615 shares — an estimated $43K sold.

Bank of New York Mellon first reported a position in PLXP in Q4 2016 and held it in 6 quarters. The position peaked at $1.32M in Q3 2021. 48 funds tracked by Wall St. Rank hold PLXP as of Q2 2022.

Bank of New York Mellon reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Bank of New York Mellon sold 10,615 PLx Pharma Inc. Common Stock shares in Q2 2022, an estimated $43K.
Bank of New York Mellon first reported a position in PLx Pharma Inc. Common Stock in Q4 2016 and held it in 6 quarters.
Bank of New York Mellon's PLx Pharma Inc. Common Stock position peaked at $1.32M in Q3 2021.
48 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.